Scholarlink

Background <p>Multiple germline variants are associated with prostate cancer (PCa) susceptibility and aggressive features; however, their value for predicting prostate cancer–specific mortality (PCSM) at the time of diagnosis remains uncertain, particularly among men with clinically localized disease.</p> Methods <p>We evaluated associations between germline risk factors and PCSM among 14,644 men with incident PCa in the UK Biobank. Associations between PCSM and reported germline risk factors, including 11 genes recommended by the National Comprehensive Cancer Network (NCCN), nine other candidate genes, two common variants [<i>KLK3</i> (I179T) and <i>HSD3B1</i> (1245 A &gt; C)], and three polygenic risk scores (PRSs), were tested using Fine–Gray competing-risk models accounting for non–PCa mortality.</p> Results <p>During a median follow-up of 6.73 years after diagnosis, 1581 men (10.8%) died from PCa. PVs in three NCCN-recommended DNA damage–repair genes (<i>BRCA2</i>, <i>MSH6</i>, <i>PALB2</i>) were individually associated with increased PCSM and were defined as Tier-1. Aggregated PVs in seven additional NCCN-recommended DDR genes (Tier-2) and the <i>KLK3</i> I179T variant were also independently associated with PCSM. In contrast, <i>HOXB13</i>, nine other candidate genes, <i>HSD3B1</i>, and all three PRSs were not associated with cumulative PCSM risk. Overall, 14.45% of men carried Tier-1 or Tier-2 PVs and/or <i>KLK3</i> I179T and experienced significantly earlier PCa-specific mortality. Importantly, associations remained significant among men without metastatic disease at diagnosis.</p> Conclusions <p>Reported inherited susceptibility to PCa does not uniformly confer risk of lethal progression. Germline PVs in NCCN-recommended DDR genes and the <i>KLK3</i> I179T variant identify a subset of men at elevated risk of PCSM, including those with apparently localized disease. These findings support consideration of selected germline markers for prognostic risk stratification at diagnosis to inform individualized management decisions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Germline genetic risk and prostate cancer–specific mortality in a population-based incident cohort

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年8月4日

查看全文
  • Lucy Lu,
  • Julian Xu,
  • Zhuqing Shi,
  • Valentina Engelmann,
  • Huy Tran,
  • Jun Wei,
  • Annabelle Ashworth,
  • Brandon Cornell,
  • Christopher Pieczonka,
  • William B. Isaacs,
  • S. Lilly Zheng,
  • Brian T. Helfand,
  • Jun Luo,
  • Jianfeng Xu,
  • Jim Lu

摘要

Background

Multiple germline variants are associated with prostate cancer (PCa) susceptibility and aggressive features; however, their value for predicting prostate cancer–specific mortality (PCSM) at the time of diagnosis remains uncertain, particularly among men with clinically localized disease.

Methods

We evaluated associations between germline risk factors and PCSM among 14,644 men with incident PCa in the UK Biobank. Associations between PCSM and reported germline risk factors, including 11 genes recommended by the National Comprehensive Cancer Network (NCCN), nine other candidate genes, two common variants [KLK3 (I179T) and HSD3B1 (1245 A > C)], and three polygenic risk scores (PRSs), were tested using Fine–Gray competing-risk models accounting for non–PCa mortality.

Results

During a median follow-up of 6.73 years after diagnosis, 1581 men (10.8%) died from PCa. PVs in three NCCN-recommended DNA damage–repair genes (BRCA2, MSH6, PALB2) were individually associated with increased PCSM and were defined as Tier-1. Aggregated PVs in seven additional NCCN-recommended DDR genes (Tier-2) and the KLK3 I179T variant were also independently associated with PCSM. In contrast, HOXB13, nine other candidate genes, HSD3B1, and all three PRSs were not associated with cumulative PCSM risk. Overall, 14.45% of men carried Tier-1 or Tier-2 PVs and/or KLK3 I179T and experienced significantly earlier PCa-specific mortality. Importantly, associations remained significant among men without metastatic disease at diagnosis.

Conclusions

Reported inherited susceptibility to PCa does not uniformly confer risk of lethal progression. Germline PVs in NCCN-recommended DDR genes and the KLK3 I179T variant identify a subset of men at elevated risk of PCSM, including those with apparently localized disease. These findings support consideration of selected germline markers for prognostic risk stratification at diagnosis to inform individualized management decisions.